NuGEN and KeyGene announce settlement in declaratory judgment lawsuit

August 13, 2018

Today NuGEN Technologies, Inc. and Keygene N.V. announced an agreement to settle a declaratory judgment lawsuit brought by NuGEN Technologies concerning KeyGene’s U.S. Patent Nos. 9,702,004, 9,745,627 and 9,896,721.  Under the terms of the settlement, the lawsuit and counterclaims have been dismissed. Financial terms and other specifics of the settlement were not disclosed.

The full press release is also available as pdf